Saha, N., Lee, S. G., Brockmann, E.-C., de la Cruz, M. J., Goldgur, Y., Mendoza, R. P., Stanchina, E. de, Love, T. M., Marvald, J., Xu, Y., Xu, K., Himanen, J. P., Lamminmäki, U., Veach, D., & Nikolov, D. B. (2024). Fully human monoclonal antibody targeting the cysteine-rich substrate-interacting region of ADAM17 on cancer cells. Biomedicine & Pharmacotherapy, 180, 117605. https://doi.org/10.1016/j.biopha.2024.117605
Columbia Affiliation:
Subjects:
HER2 Signaling in Breast Cancer Treatment
(OpenAlex Topic)
Therapeutic Antibodies: Development, Engineering, and Applications
(OpenAlex Topic)
Development and Applications of Radiopharmaceuticals
(OpenAlex Topic)
ADAM17 Protein
(MeSH)
Antibodies, Monoclonal
(MeSH)
ErbB Receptors
(MeSH)
Publication Type:
Article
Unique ID:
10.1016/j.biopha.2024.117605
PMID:
Journal:
Publication Date:
Data Source:
PubMed
Source Link: